BIG
XLNX

Boothe Investment Group’s Xilinx Inc XLNX Stock Holding History

Boothe Investment Group’s Portfolio XLNX Stock Details XLNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,333
Closed -$5.16M – 38
2021
Q4 		$5.16M Sell
24,333
-19,795
-45% -$3.9M 2.76% 17
2021
Q3 		$6.7M Buy
44,128
+975
+2% +$143K 3.66% 13
2021
Q2 		$6.12M Buy
43,153
+1,691
+4% +$215K 3.21% 16
2021
Q1 		$5.14M Buy
41,462
+5,284
+15% +$704K 2.99% 17
2020
Q4 		$5.13M Buy
36,178
+529
+1% +$68.8K 3.54% 15
2020
Q3 		$3.72M Buy
35,649
+127
+0.4% +$13K 3.17% 14
2020
Q2 		$3.5M Buy
+35,522
New +$3.15M 3.09% 15
2019
Q4 		$2.32M Buy
23,770
+420
+2% +$39.5K 2.37% 17
2019
Q3 		$2.24M Buy
23,350
+6
+0% +$657 2.36% 17
2019
Q2 		$2.75M Buy
+23,344
New +$2.72M 3.37% 12

Other funds holding XLNX

PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.34B AUM 15.38% 1-Year Est. Return

Boothe Investment Group's XLNX Position: Q1 2022 in Review

Boothe Investment Group sold out of Xilinx Inc (XLNX) in Q1 2022, closing a stake of 24,333 shares — an estimated $5.16M sold.

Boothe Investment Group first reported a position in XLNX in Q2 2019 and held it in 10 quarters. The position peaked at $6.7M in Q3 2021. 4 funds tracked by Wall St. Rank hold XLNX as of Q1 2022.

  • Boothe Investment Group reported no remaining Xilinx Inc position as of Q1 2022 after selling out during the quarter.
  • Boothe Investment Group sold 24,333 Xilinx Inc shares in Q1 2022, an estimated $5.16M.
  • Boothe Investment Group first reported a position in Xilinx Inc in Q2 2019 and held it in 10 quarters.
  • Boothe Investment Group's Xilinx Inc position peaked at $6.7M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Xilinx Inc as of Q1 2022.

Based on Boothe Investment Group's 13F filing for Q1 2022, filed 11 May 2022.